Sign in
4

Changes in Ownership

SANGAMO THERAPEUTICS, INC Filed Acc 0001415889-25-005708

Head of Research & Technology gave up 1,212 shares (to pay taxes)

  • Head of Research & Technology acquired 49,726 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Davis Gregory D · Head of Research & Technology

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-24 Shares withheld for taxes : show line 1 in the form −705 $1.00 $705 166,865 D
2025-02-25 Shares withheld for taxes : show line 2 in the form −507 $0.96 $485 166,358 D
2025-02-25 Grant or award : show line 3 in the form +49,726 216,084 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-25 Grant or award : show line 4 in the form Stock Option (Right to Buy) +99,454 99,454 D
Loading xslF345X05/form4-02262025_100209.xml…